Abstract:The gut immune system in the healthy intestine is anti-inflammatory, but can move to a pro-inflammatory state when the gut is challenged by pathogens or in disease. The nervous system influences the level of inflammation through enteric neurons and extrinsic neural connections, particularly vagal and sympathetic innervation of the gastrointestinal tract, each of which exerts anti-inflammatory effects. Within the enteric nervous system (ENS), three neuron types that influence gut immune cells have been identified, intrinsic primary afferent neurons (IPANs), vasoactive intestinal peptide (VIP) neurons that project to the mucosa, and cholinergic neurons that influence macrophages in the external muscle layers. The enteric neuropeptides, calcitonin gene-related peptide (CGRP), tachykinins, and neuromedin U (NMU), which are contained in IPANs, and VIP produced by the mucosa innervating neurons, all influence immune cells, notably innate lymphoid cells (ILCs). ILC2 are stimulated by VIP to release IL-22, which promotes microbial defense and tissue repair. Enteric neurons are innervated by the vagus, and, in the large intestine, by the pelvic nerves. Vagal nerve stimulation reduces gut inflammation, which may be both by stimulation of efferent (motor) pathways to the ENS, and stimulation of afferent pathways that connect to integrating centers in the CNS. Efferent pathways from the CNS have their anti-inflammatory effects through either or both vagal efferent neurons and sympathetic pathways. The final neurons in sympathetic pathways reduce gut inflammation by the action of noradrenaline on β2 adrenergic receptors expressed by immune cells. Activation of neural anti-inflammatory pathways is an attractive option to treat inflammatory bowel disease that is refractory to other treatments. Further investigation of the ways in which enteric reflexes, vagal pathways and sympathetic pathways integrate their effects to modulate the gut immune system and gut inflammation is needed to optimize neuromodulation therapy.

Gut hormones: emerging role in immune activation and inflammation

Intestinal Crosstalk Between Microbiota and Serotonin and Its Impact on Gut Motility

Emerging Roles of Gut Serotonin in Regulation of Immune Response, Microbiota Composition and Intestinal Inflammation

The emerging role of gut hormones

Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut

Exploration of gut microbiome and inflammation: A review on key signalling pathways

Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation

Gut-brain axis interacts with immunomodulation in inflammatory bowel disease

The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

Signaling inflammation across the gut-brain axis

Tryptophan‐derived serotonin‐kynurenine balance in immune activation and intestinal inflammation

Neuroendocrine stimulation of mucosal immune cells in inflammatory bowel disease

Interaction Between Microbes and Host Intestinal Health: Modulation by Dietary Nutrients and Gut-Brain-Endocrine-Immune Axis

The bi-directional role of the gut-brain axis in inflammatory and other gastrointestinal diseases

The crosstalk between gut bacteria and host immunity in intestinal inflammation

Neuronal regulation of the gut immune system and neuromodulation for treating inflammatory bowel disease

Neuroinflammation in the Brain and Role of Intestinal Microbiota: An Overview of the Players